Liaoning Chengda disclosed its earnings forecast, estimating net profit attributable to shareholders of the parent company for the first half of 2026 at 1.452 billion to 1.71 billion yuan, a year-on-year increase of 102.28% to 138.32%. Net profit after deducting non-recurring items is expected to be 1.455 billion to 1.714 billion yuan, up 104.39% to 140.71% year-on-year. The company stated that the main reason for the significant growth in performance is the year-on-year increase in investment income. Liaoning Chengda's business spans four major segments: pharmaceutical and healthcare, financial investment, domestic and international trade, and energy development.
Liaoning Cheng Da Co LtdCompany forecasts 102%-138% net profit growth driven by higher investment income.